Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Inventory (2016 - 2025)

Tandem Diabetes Care's Change in Inventory history spans 13 years, with the latest figure at -$7.6 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 1171.26% year-over-year to -$7.6 million; the TTM value through Dec 2025 reached -$24.8 million, down 327.13%, while the annual FY2025 figure was -$24.8 million, 327.13% down from the prior year.
  • Change in Inventory reached -$7.6 million in Q4 2025 per TNDM's latest filing, down from -$5.2 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $19.9 million in Q1 2023 to a low of -$10.4 million in Q3 2024.
  • Average Change in Inventory over 5 years is $3.1 million, with a median of $1.5 million recorded in 2021.
  • Peak YoY movement for Change in Inventory: skyrocketed 7149.58% in 2022, then crashed 1171.26% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $3.0 million in 2021, then soared by 78.24% to $5.4 million in 2022, then skyrocketed by 147.48% to $13.3 million in 2023, then tumbled by 104.46% to -$595000.0 in 2024, then plummeted by 1171.26% to -$7.6 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Change in Inventory are -$7.6 million (Q4 2025), -$5.2 million (Q3 2025), and -$2.5 million (Q2 2025).